Cargando…
Nephrogenic Systemic Fibrosis Risk After Liver Magnetic Resonance Imaging With Gadoxetate Disodium in Patients With Moderate to Severe Renal Impairment: Results of a Prospective, Open-Label, Multicenter Study
OBJECTIVE: The objective of this study was to assess the risk of gadoxetate disodium in liver imaging for the development of nephrogenic systemic fibrosis (NSF) in patients with moderate to severe renal impairment. MATERIALS AND METHODS: We performed a prospective, multicenter, nonrandomized, open-l...
Autores principales: | Lauenstein, Thomas, Ramirez-Garrido, Francisco, Kim, Young Hoon, Rha, Sung Eun, Ricke, Jens, Phongkitkarun, Sith, Boettcher, Joachim, Gupta, Rajan T., Korpraphong, Pornpim, Tanomkiat, Wiwatana, Furtner, Julia, Liu, Peter S., Henry, Maren, Endrikat, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420151/ https://www.ncbi.nlm.nih.gov/pubmed/25756684 http://dx.doi.org/10.1097/RLI.0000000000000145 |
Ejemplares similares
-
Safety profile of gadoxetate disodium in elderly patients (≥65 years)
por: Endrikat, Jan, et al.
Publicado: (2017) -
Safety of gadoxetate disodium: results from six clinical phase IV studies in 8194 patients
por: Endrikat, Jan, et al.
Publicado: (2015) -
Safety and Efficacy of Gadoxetate Disodium–Enhanced Liver MRI in Pediatric Patients Aged >2 Months to <18 Years—Results of a Retrospective, Multicenter Study
por: Geller, James, et al.
Publicado: (2016) -
Diagnostic Efficacy and Safety of Gadoxetate Disodium vs Gadobenate
Dimeglumine in Patients With Known or Suspected Focal Liver Lesions: Results of
a Clinical Phase III Study
por: Zech, Christoph J, et al.
Publicado: (2019) -
Randomized multicentre trial of gadoxetic acid-enhanced MRI versus conventional MRI or CT in the staging of colorectal cancer liver metastases
por: Zech, C J, et al.
Publicado: (2014)